Evidence map›Paper›PMID 32838380›Full record

ArticleJournal of the American College of Emergency Physicians open2020

Viral and atypical respiratory co-infections in COVID-19: a systematic review and meta-analysis.

Bennett Davis, Ava N Rothrock, Sarah Swetland, Halle Andris, Phil Davis, Steven G Rothrock

Abstract read
In one paragraph

Article in Journal of the American College of Emergency Physicians open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Clinical Features of Long COVID Patients Coinfected WithThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. A review on oral manifestations of COVID-19 disease.Journal of family medicine and primary care · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  17. Article
  18. Article
  19. The interface between COVID-19 and bacterial healthcare-associated infections.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bennett DavisUniversity of Queensland Ochsner Clinical School Brisbane, Australia and New Orleans New Orleans Louisiana USA.
Ava N RothrockDr. P. Phillips Hospital Orlando Health Orlando Florida USA.
Sarah SwetlandDr. P. Phillips Hospital Orlando Health Orlando Florida USA.
Halle AndrisDr. P. Phillips Hospital Orlando Health Orlando Florida USA.
Phil DavisDr. P. Phillips Hospital Orlando Health Orlando Florida USA.
Steven G RothrockDr. P. Phillips Hospital Orlando Health Orlando Florida USA.ORCID https://orcid.org/0000-0003-3528-662X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Respiratory co-infections have the potential to affect the diagnosis and treatment of COVID-19 patients. This meta-analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID-19 patients. Methods: This review was consistent with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Searched databases included: PubMed, EMBASE, Web of Science, Google Scholar, and grey literature. Studies with a series of SARS-CoV-2-positive patients with additional respiratory pathogen testing were included. Independently, 2 authors extracted data and assessed quality of evidence across all studies using Cochrane's Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and within each study using the Newcastle Ottawa scale. Data extraction and quality assessment disagreements were settled by a third author. Pooled prevalence of co-infections was calculated using a random-effects model with univariate meta-regression performed to assess the effect of study subsets on heterogeneity. Publication bias was evaluated using funnel plot inspection, Begg's correlation, and Egger's test. Results: Eighteen retrospective cohorts and 1 prospective study were included. Pooling of data (1880 subjects) showed an 11.6% (95% confidence interval [CI] = 6.9-17.4, Conclusion: Co-infection with respiratory pathogens is a common and potentially important occurrence in patients with COVID-19. Knowledge of the prevalence and type of co-infections may have diagnostic and management implications.

Indexed as

COVID‐19humaninfluenzamycoplasmapneumoniarespiratory tract infectionsviral

Identifiers

PMID32838380
PMCPMC7323310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.